Literature DB >> 24622039

Early changes in serum visfatin after abdominal surgery: a new pro-inflammatory marker in diagnosis?

Vladimir Teplan3, Ladislav Senolt2, Hana Hulejova2, Vladimir Teplan3, Milena Stollova3, Robert Gurlich1.   

Abstract

BACKGROUND: Visfatin is an adipocytokine produced primarily by visceral adipose tissue. In addition to its effect on the insulin receptor, it is a proinflammmatory cytokine with accumulating evidence for its rise in circulation, accompanying systemic inflammation. The aim of this study was to evaluate changes in serum visfatin levels in the early post-abdominal surgery period with serum levels of other proinflammatory cytokines, to determine whether it could be used as a marker of inflammation. METHODS AND
RESULTS: This was a prospective cross-sectional study of 42 patients undergoing elective laparotomic right hemicolectomy for adenocarcinoma colon. The parameters determined were visfatin, leptin, adiponectin, TNF α, interleukin-6 and C-reactive protein levels. The dynamics of change in these markers were assessed at +12, +24, +48, and +72 h after surgery. Serum levels of visfatin peaked as early as 24 h post-surgery, returning to normal after 72 h. TNF α and IL-6 levels reached their maximum 12 to 24 h later while CRP levels peaked after 72 h.
CONCLUSIONS: Significantly increased serum levels of visfatin detected in the early period after abdominal surgery preceded increase in the levels of other proinflammatory markers including TNF α, IL-6, and CRP. Given its dynamics, visfatin could serve as an early predictor of the development of inflammatory changes in patients undergoing surgery, particularly those with obesity (BMI > 30 kg/m(2)).

Entities:  

Keywords:  abdominal surgery; proinflammatory cytokines; visceral obesity; visfatin

Mesh:

Substances:

Year:  2014        PMID: 24622039     DOI: 10.5507/bp.2014.012

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  3 in total

1.  Visfatin level in patients with colorectal adenoma.

Authors:  Mohammad Sadegh Fazeli; Mohammad Reza Keramati; Azam Rahimi; Alireza Kazemeini; Mohammad Mehdi Banoei; Habibollah Dashti; Amir Reza Fazeli
Journal:  Med J Islam Repub Iran       Date:  2016-01-24

2.  Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences.

Authors:  Alexandru Florescu; Dumitru Branisteanu; Stefana Bilha; Dragos Scripcariu; Ioana Florescu; Viorel Scripcariu; Gabriel Dimofte; Ioana Grigoras
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

3.  Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus.

Authors:  Zhaoxia Liang; Ying Wu; Jianyun Xu; Qin Fang; Danqing Chen
Journal:  J Diabetes Investig       Date:  2015-07-23       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.